Global Topical Corticosteroids Market Report (2025–2036)
Market Overview
The global topical corticosteroids market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Increasing prevalence of dermatological conditions such as eczema, psoriasis, and dermatitis, coupled with rising demand for effective anti-inflammatory treatments, is driving market growth. The market is characterized by a wide range of formulations including ointments, creams, gels, and sprays, catering to both hospital and retail pharmacy channels.
Impact of COVID-19
The pandemic disrupted supply chains and delayed dermatological consultations in 2020. However, demand for topical corticosteroids remained resilient as patients continued to require treatment for chronic skin conditions. Post-pandemic, telemedicine and e-pharmacy platforms have accelerated product accessibility.
Segmentation Analysis
By Type
· Ointments
· Creams
· Gels
· Lotions
· Sprays
· Others
By Application
· Hospitals
· Dermatology Clinics
· Pharmacies & Retail Drugstores
· Online Pharmacies
· Others
By Potency
· Low Potency
· Medium Potency
· High Potency
· Super Potent
Regional Analysis
· North America: Leading market due to high prevalence of dermatological conditions, advanced healthcare infrastructure, and strong presence of pharmaceutical companies.
· Europe: Growth supported by government-funded healthcare systems and widespread adoption of topical therapies.
· Asia-Pacific: Fastest-growing region, driven by rising population, increasing awareness of skin health, and expanding pharmaceutical distribution in India and China.
· South America: Moderate growth, with Brazil leading in dermatology care.
· Middle East & Africa: Emerging opportunities with increasing healthcare investments and rising demand for affordable dermatology treatments.
Key Players
· AstraZeneca plc
· GlaxoSmithKline plc
· Merck & Co. Inc.
· Pfizer Inc.
· Sandoz AG (Novartis AG)
· Sanofi S.A.
· Actimis Pharmaceuticals
· Valeant Pharmaceuticals (Bausch Health Companies Inc.)
· Almirall S.A.
· Zylera Pharmaceuticals
· Johnson & Johnson
· AbbVie Inc.
· Eli Lilly and Company
· Bristol Myers Squibb
· Cipla Ltd.
· Sun Pharmaceutical Industries Ltd.
Porter’s Five Forces
· Threat of New Entrants: Low, due to high regulatory requirements and R&D costs.
· Bargaining Power of Suppliers: Moderate, with reliance on specialized raw materials.
· Bargaining Power of Buyers: High, as patients and healthcare providers demand cost-effective therapies.
· Threat of Substitutes: Moderate, with alternatives like biologics and non-steroidal treatments.
· Industry Rivalry: High, with global and regional players competing on innovation and pricing.
SWOT Analysis
Strengths: Proven efficacy in treating dermatological conditions, wide availability across formulations. Weaknesses: Risk of side effects with prolonged use, regulatory scrutiny. Opportunities: Growth in emerging markets, innovation in safer formulations. Threats: Competition from biologics and novel dermatology therapies, counterfeit products.
Trend Analysis
· Rising demand for safer, low-potency corticosteroids.
· Increasing adoption of combination therapies (corticosteroids + antifungals/antibiotics).
· Growth in online pharmacy distribution.
· Expansion of dermatology-focused R&D investments.
Drivers & Challenges
Drivers:
· Rising prevalence of chronic dermatological conditions.
· Increasing awareness of skin health.
· Strong demand for affordable topical therapies.
Challenges:
· Side effects associated with long-term use.
· Regulatory hurdles for new product approvals.
· Intense competition from biologics and alternative therapies.
Value Chain Analysis
· Raw Material Suppliers (active pharmaceutical ingredients) → Manufacturers → Distributors/Pharmacies → Hospitals/Clinics/Consumers
· E-pharmacy platforms and telemedicine are reshaping the value chain, improving accessibility and patient compliance.
Recommendations for Stakeholders
· Manufacturers: Invest in safer, innovative formulations and expand into emerging markets.
· Healthcare Providers: Promote responsible use and patient education to minimize side effects.
· Investors: Focus on Asia-Pacific for high growth potential.
· Policy Makers: Support affordable dermatology treatments and strengthen regulatory frameworks for safety.
1. Market Overview of Topical Corticosteroids
1.1 Topical Corticosteroids Market Overview
1.1.1 Topical Corticosteroids Product Scope
1.1.2 Market Status and Outlook
1.2 Topical Corticosteroids Market Size by Regions:
1.3 Topical Corticosteroids Historic Market Size by Regions
1.4 Topical Corticosteroids Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Topical Corticosteroids Sales Market by Type
2.1 Global Topical Corticosteroids Historic Market Size by Type
2.2 Global Topical Corticosteroids Forecasted Market Size by Type
2.3 Ointments
2.4 Creams
2.5 Others
3. Covid-19 Impact Topical Corticosteroids Sales Market by Application
3.1 Global Topical Corticosteroids Historic Market Size by Application
3.2 Global Topical Corticosteroids Forecasted Market Size by Application
3.3 Hospitals
3.4 Dermatology Clinics
3.5 Pharmacies
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Topical Corticosteroids Production Capacity Market Share by Manufacturers
4.2 Global Topical Corticosteroids Revenue Market Share by Manufacturers
4.3 Global Topical Corticosteroids Average Price by Manufacturers
5. Company Profiles and Key Figures in Topical Corticosteroids Business
5.1 AstraZeneca plc
5.1.1 AstraZeneca plc Company Profile
5.1.2 AstraZeneca plc Topical Corticosteroids Product Specification
5.1.3 AstraZeneca plc Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.2 GlaxoSmithKline plc
5.2.1 GlaxoSmithKline plc Company Profile
5.2.2 GlaxoSmithKline plc Topical Corticosteroids Product Specification
5.2.3 GlaxoSmithKline plc Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.3 Merck & Co. Inc.
5.3.1 Merck & Co. Inc. Company Profile
5.3.2 Merck & Co. Inc. Topical Corticosteroids Product Specification
5.3.3 Merck & Co. Inc. Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.4 Pfizer Inc.
5.4.1 Pfizer Inc. Company Profile
5.4.2 Pfizer Inc. Topical Corticosteroids Product Specification
5.4.3 Pfizer Inc. Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.5 Sandoz AG (Novartis AG)
5.5.1 Sandoz AG (Novartis AG) Company Profile
5.5.2 Sandoz AG (Novartis AG) Topical Corticosteroids Product Specification
5.5.3 Sandoz AG (Novartis AG) Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.6 Sanofi S.A.
5.6.1 Sanofi S.A. Company Profile
5.6.2 Sanofi S.A. Topical Corticosteroids Product Specification
5.6.3 Sanofi S.A. Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.7 Actimis Pharmaceuticals
5.7.1 Actimis Pharmaceuticals Company Profile
5.7.2 Actimis Pharmaceuticals Topical Corticosteroids Product Specification
5.7.3 Actimis Pharmaceuticals Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.8 Valeant Pharmaceuticals
5.8.1 Valeant Pharmaceuticals Company Profile
5.8.2 Valeant Pharmaceuticals Topical Corticosteroids Product Specification
5.8.3 Valeant Pharmaceuticals Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.9 Almirall
5.9.1 Almirall Company Profile
5.9.2 Almirall Topical Corticosteroids Product Specification
5.9.3 Almirall Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.10 S.A
5.10.1 S.A Company Profile
5.10.2 S.A Topical Corticosteroids Product Specification
5.10.3 S.A Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
5.11 Zylera Pharmaceuticals
5.11.1 Zylera Pharmaceuticals Company Profile
5.11.2 Zylera Pharmaceuticals Topical Corticosteroids Product Specification
5.11.3 Zylera Pharmaceuticals Topical Corticosteroids Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Topical Corticosteroids Market Size
6.2 North America Topical Corticosteroids Key Players in North America
6.3 North America Topical Corticosteroids Market Size by Type
6.4 North America Topical Corticosteroids Market Size by Application
7. East Asia
7.1 East Asia Topical Corticosteroids Market Size
7.2 East Asia Topical Corticosteroids Key Players in North America
7.3 East Asia Topical Corticosteroids Market Size by Type
7.4 East Asia Topical Corticosteroids Market Size by Application
8. Europe
8.1 Europe Topical Corticosteroids Market Size
8.2 Europe Topical Corticosteroids Key Players in North America
8.3 Europe Topical Corticosteroids Market Size by Type
8.4 Europe Topical Corticosteroids Market Size by Application
9. South Asia
9.1 South Asia Topical Corticosteroids Market Size
9.2 South Asia Topical Corticosteroids Key Players in North America
9.3 South Asia Topical Corticosteroids Market Size by Type
9.4 South Asia Topical Corticosteroids Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Topical Corticosteroids Market Size
10.2 Southeast Asia Topical Corticosteroids Key Players in North America
10.3 Southeast Asia Topical Corticosteroids Market Size by Type
10.4 Southeast Asia Topical Corticosteroids Market Size by Application
11. Middle East
11.1 Middle East Topical Corticosteroids Market Size
11.2 Middle East Topical Corticosteroids Key Players in North America
11.3 Middle East Topical Corticosteroids Market Size by Type
11.4 Middle East Topical Corticosteroids Market Size by Application
12. Africa
12.1 Africa Topical Corticosteroids Market Size
12.2 Africa Topical Corticosteroids Key Players in North America
12.3 Africa Topical Corticosteroids Market Size by Type
12.4 Africa Topical Corticosteroids Market Size by Application
13. Oceania
13.1 Oceania Topical Corticosteroids Market Size
13.2 Oceania Topical Corticosteroids Key Players in North America
13.3 Oceania Topical Corticosteroids Market Size by Type
13.4 Oceania Topical Corticosteroids Market Size by Application
14. South America
14.1 South America Topical Corticosteroids Market Size
14.2 South America Topical Corticosteroids Key Players in North America
14.3 South America Topical Corticosteroids Market Size by Type
14.4 South America Topical Corticosteroids Market Size by Application
15. Rest of the World
15.1 Rest of the World Topical Corticosteroids Market Size
15.2 Rest of the World Topical Corticosteroids Key Players in North America
15.3 Rest of the World Topical Corticosteroids Market Size by Type
15.4 Rest of the World Topical Corticosteroids Market Size by Application
16 Topical Corticosteroids Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segmentation Analysis
By Type
· Ointments
· Creams
· Gels
· Lotions
· Sprays
· Others
By Application
· Hospitals
· Dermatology Clinics
· Pharmacies & Retail Drugstores
· Online Pharmacies
· Others
By Potency
· Low Potency
· Medium Potency
· High Potency
· Super Potent
Regional Analysis
· North America: Leading market due to high prevalence of dermatological conditions, advanced healthcare infrastructure, and strong presence of pharmaceutical companies.
· Europe: Growth supported by government-funded healthcare systems and widespread adoption of topical therapies.
· Asia-Pacific: Fastest-growing region, driven by rising population, increasing awareness of skin health, and expanding pharmaceutical distribution in India and China.
· South America: Moderate growth, with Brazil leading in dermatology care.
· Middle East & Africa: Emerging opportunities with increasing healthcare investments and rising demand for affordable dermatology treatments.
Key Players
· AstraZeneca plc
· GlaxoSmithKline plc
· Merck & Co. Inc.
· Pfizer Inc.
· Sandoz AG (Novartis AG)
· Sanofi S.A.
· Actimis Pharmaceuticals
· Valeant Pharmaceuticals (Bausch Health Companies Inc.)
· Almirall S.A.
· Zylera Pharmaceuticals
· Johnson & Johnson
· AbbVie Inc.
· Eli Lilly and Company
· Bristol Myers Squibb
· Cipla Ltd.
· Sun Pharmaceutical Industries Ltd.
